A critical breakthrough in cancer research is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial cancer protector protein is frequently inactivated in several kinds of cancer, resulting https://my-social-box.com/story7456531/mini-antibodies-restore-tumor-suppressor-p53-a-promising-pathway-for-malignant-management